Results 231 to 240 of about 144,436 (251)

Immune Checkpoint Inhibitor–Induced Myocarditis with Myositis/Myasthenia Gravis Overlap Syndrome: A Systematic Review of Cases

Oncologist, 2021
Ranjan Pathak, Anjan Katel, Erminia Massarelli   +2 more
exaly  

Biomarkers for immune checkpoint inhibitors

The Lancet Oncology, 2014
Lysanne A, Lievense, Joost P J J, Hegmans, Joachim G J V, Aerts   +2 more
openaire   +2 more sources

Immune checkpoint inhibitor diabetes mellitus: a novel form of autoimmune diabetes

Clinical and Experimental Immunology, 2020
Mark S Anderson, Young A
exaly  

Identification of Pathogenic Immune Cell Subsets Associated With Checkpoint Inhibitor–Induced Myocarditis

Circulation, 2022
Han Zhu, Sarah Waliany, Joel W Neal
exaly  

Immune checkpoint inhibitor-associated myopathy: a clinicoseropathologically distinct myopathy

Brain Communications, 2020
Shahar Shelly, James D Triplett, Marcus V Pinto   +2 more
exaly  

Decreased Absolute Lymphocyte Count and Increased Neutrophil/Lymphocyte Ratio With Immune Checkpoint Inhibitor–Associated Myocarditis

Journal of the American Heart Association, 2020
Zsófia Dora Drobni, Amna Zafar, Raza M Alvi   +2 more
exaly  

Cardiac myosin-specific autoimmune T cells contribute to immune-checkpoint-inhibitor-associated myocarditis

Cell Reports, 2022
Taejoon Won, Mónica V Talor, Ninaad Lasrado   +2 more
exaly  

Immune Checkpoint Inhibitor Therapy Induces Inflammatory Activity in Large Arteries

Circulation, 2020
Raffaella Calabretta, Christoph Hoeller, Verena Pichler   +2 more
exaly  

Clinical diagnosis and treatment of immune checkpoint inhibitor‐associated pneumonitis

Thoracic Cancer, 2020
Hanping Wang, Jiaxin Zhou, Yue Li
exaly  

Cardiomuscular Biomarkers in the Diagnosis and Prognostication of Immune Checkpoint Inhibitor Myocarditis

Circulation, 2023
Lorenz H Lehmann, Markus B Heckmann, Daniel Finke   +2 more
exaly